IDiyas

For the Inventor, By the Inventor

Gales Ferry, CT, United States of America

Judith L Treadway

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • Gales Ferry, CT (US) (1999 - 2005)
  • Mystic, CT (US) (2002 - 2005)

Company Filing History:

goldMedal11 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1999-2005

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6867202 - Treatment of insulin resistance (2005-03-15),
2. 6867184 - Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors (2005-03-15),
3. 6846820 - Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors (2005-01-25),
4. 6649634 - Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors (2003-11-18),
5. 6630487 - Treatment of insulin resistance with growth hormone secretagogues (2003-10-07),
6. 6555569 - Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection (2003-04-29),
7. 6448263 - Treatment of insulin resistance with growth hormone secretagogues (2002-09-10),
8. 6297269 - Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors (2001-10-02),
9. 6277877 - Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors (2001-08-21),
10. 6107329 - Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as (2000-08-22),
11. 5952322 - Method of reducing tissue damage associated with non-cardiac ischemia (1999-09-14),

Title: Innovations and Contributions of Judith L Treadway

Introduction

Judith L Treadway is a prominent inventor based in Gales Ferry, Connecticut. She has made significant contributions to the field of medicine, particularly in the treatment of diabetic cardiomyopathy and insulin resistance. With a total of 11 patents to her name, Treadway's work has the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

Among her latest patents, Treadway has developed methods for treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors. This invention provides methods for administering a therapeutically effective amount of a glycogen phosphorylase inhibitor to patients at risk of diabetic cardiomyopathy. Additionally, she has created methods for treating insulin resistance in mammals, which involve administering compounds that increase the level of endogenous growth hormone. These innovations highlight her commitment to advancing medical treatments.

Career Highlights

Judith L Treadway has built a successful career at Pfizer Corporation, where she has been instrumental in developing groundbreaking therapies. Her expertise in pharmacology and her innovative approach to treatment have earned her recognition in the pharmaceutical industry. Treadway's work exemplifies the intersection of science and healthcare, showcasing her dedication to improving patient outcomes.

Collaborations

Throughout her career, Treadway has collaborated with notable colleagues, including Dennis J Hoover and William H Martin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of medical research.

Conclusion

Judith L Treadway's contributions to the field of medicine through her patents and collaborations demonstrate her innovative spirit and commitment to improving healthcare. Her work continues to inspire future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…